Cetera Advisors’s Charles River Laboratories CRL Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | $910K | Buy |
3,357
+2,227
| +197% | +$603K | 0.01% | 1209 |
|
2023
Q4 | $267K | Buy |
+1,130
| New | +$267K | ﹤0.01% | 1491 |
|
2023
Q3 | – | Sell |
-966
| Closed | -$203K | – | 1715 |
|
2023
Q2 | $203K | Buy |
+966
| New | +$203K | ﹤0.01% | 1503 |
|
2023
Q1 | – | Sell |
-1,055
| Closed | -$230K | – | 1653 |
|
2022
Q4 | $230K | Buy |
+1,055
| New | +$230K | ﹤0.01% | 1374 |
|
2022
Q2 | – | Sell |
-750
| Closed | -$213K | – | 1377 |
|
2022
Q1 | $213K | Sell |
750
-230
| -23% | -$65.3K | ﹤0.01% | 1283 |
|
2021
Q4 | $369K | Sell |
980
-515
| -34% | -$194K | 0.01% | 1017 |
|
2021
Q3 | $617K | Buy |
1,495
+755
| +102% | +$312K | 0.01% | 799 |
|
2021
Q2 | $274K | Buy |
740
+7
| +1% | +$2.59K | 0.01% | 1096 |
|
2021
Q1 | $212K | Buy |
+733
| New | +$212K | 0.01% | 1123 |
|